Neurocrine Bioscience buy Truist Financial Co.
Start price
03.08.26
/
50%
€147.15
Target price
03.08.27
€184.76
Performance (%)
-2.14%
Price
04.08.26
€144.00
Summary
This prediction is currently active. With a performance of -2.14%, the BUY prediction for Neurocrine Bioscience by Truist_Financial_Co_ is down slightly. This prediction currently runs until 03.08.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -2.14% |
| iShares Core DAX® | 3.258% |
| iShares Nasdaq 100 | 5.697% |
| iShares Nikkei 225® | 7.770% |
| iShares S&P 500 | 2.795% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Truist Financial Corporation from $200.00 to $213.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€154.55
13.07.26
13.07.26
€175.50
13.07.27
13.07.27
-6.83%
04.08.26
04.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€127.50
07.05.26
07.05.26
€131.84
07.05.27
07.05.27
12.94%
04.08.26
04.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
33.52%
04.08.26
04.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
23.34%
04.08.26
04.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
20.65%
04.08.26
04.08.26